Phase II study of lapatinib in combination with vinorelbine in patients with HER2 positive recurrent or metastatic breast cancer: A multicentric Turkish Oncology Group (TOG) trial

✍ Scribed by Saip, P.; Eralp, Y.; Sen, F.; Karaca, H.; Ozkan, M.; Cetin, B.; Benekli, M.; Kucukoner, M.; Isikdogan, A.; Un, O.; Basaran, G.; Onur, H.

• Book ID: 121403674
• Publisher: Elsevier Science
• Year: 2013
• Tongue: English
• Weight: 232 KB
• Volume: 22
• Category: Article
• ISSN: 0960-9776
• DOI: 10.1016/j.breast.2013.07.048